Efficiency of cerebrolysin in the diabetic polyneuropathy in patients with insulin-dependency diabetes mellitus

Bogdanov É.I.; Sakovets T.G.

doi:https://doi.org/

Bogdanov É.I.

Kafedra nevrologii i reabilitatsii Kazanskogo gosudarstvennogo meditsinskogo universiteta

ORCID: 0000-0001-9332-8053

Sakovets T.G.

Efficiency of cerebrolysin in the diabetic polyneuropathy in patients with insulin-dependency diabetes mellitus

Authors:

Bogdanov É.I., Sakovets T.G.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(2): 35‑39

Read: 6731 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Bogdanov ÉI, Sakovets TG. Efficiency of cerebrolysin in the diabetic polyneuropathy in patients with insulin-dependency diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(2):35‑39. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Cerebrolysin and the optimal timing of anticoagulation resumption in stroke: combined post hoc survival analysis of the CEREHETIS trial. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):77-93

Potential of animal-derived neuropeptides in complex therapy of diabetic neuropathy in patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):83-87

Early diagnosis and effective therapy of diabetic polyneuropathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):62-68

Cerebrolysin with reperfusion therapy in ischemic stroke: a prospective analysis of multimodal brain imaging data from the CEREHETIS trial. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):84-98

The influence of endometriosis on the quality of life and reproductive function of modern woman. Russian Journal of Human Reproduction. 2024;(5):101-107

Neurometabolic therapy with Cerebrolysin in patients with sepsis-associated encephalopathy. Russian Journal of Anesthesiology and Reanimatology. 2024;(6):46-54

Efficacy and safety of metamizole sodium for pain syndrome in adults and children: a systematic review. Russian Journal of Pain. 2024;(4):65-80

Transversus abdominis plane block for laparoscopic cholecystectomy in short-term acute care hospital. Pirogov Russian Journal of Surgery. 2024;(12):13-19

β-Adrenoreceptors types 1 and 2 in the diagnosis of pain syndrome in patientswith various forms of adenomyosis. Russian Journal of Human Reproduction. 2025;(1):35-43

Pharmacological pain management in pediatric intensive care. Russian Journal of Pain. 2025;(1):56-61

Abstract:

78 patients with clinical features of diabetic polyneuropathy have been examined. 39 patients, who took cerebrolysin, compose the basic group, 39 patients, who made up control one, took milgamma. The dynamics of clinical signs of the diabetic polyneuropathy was evaluated by difference of points in the first and the second examination with the use of scales: NSC (Neuropathy Symptoms and Change) and NDS (Neuropathy Dysfunction Score); the visual analog scale (VAS) and changes of the signs of orthostatic test. For the detection of the effectiveness of treatment was estimated dynamics of neuropathic disorders represented in patient with diabetes mellitus types I and II (with secondary insulin-dependency), witch allowed to reveal the considerable therapeutic effectiveness of cerebrolysin in treatment of diabetic polyneuropathic disorders.

Keywords:

diabetic polyneuropathy

cerebrolysin

pain syndrome

Authors:

Bogdanov É.I.

Kafedra nevrologii i reabilitatsii Kazanskogo gosudarstvennogo meditsinskogo universiteta

ORCID: 0000-0001-9332-8053

Sakovets T.G.

Close metadata

References:

Ametov A.S., Mamedova I.N. Lechenie α-lipoevoi kislotoi (berlitionom) perifericheskoi vegetativnoi nedostatochnosti u bol'nykh sakharnym diabetom 2-go tipa. Klin farmakol i terapiya 2003; 12: 2: 74-80.
Bogdanov E.I., Talantov V.V., Mukhametzyanov R.Z. Nevrologicheskie oslozhneniya sakharnogo diabeta. Metod. posobie. Chast' I. Kazan': KGMU 2000.
Bogdanov E.I., Sakovets T.G., Gil'mullin I.F. Vliyanie terapii tserebrolizinom na dinamiku proyavlenii diabeticheskoi polineiropatii. Zhurn nevrol i psikhiat 2009; 109: 9: 31-34.
Zinov'ev O.V., Saltykova B.B., Gorbacheva F.E. Osobennosti patogeneza i klinicheskikh proyavlenii distal'noi diabeticheskoi neiropatii u bol'nykh sakharnym diabetom 1-go i 2-go tipov. Nevrol zhurn 2006; 11: 5: 14-20.
Strokov I.A., Kozlova N.A., Mozolevskii Yu.E. i dr. Effektivnost' vnutrivennogo vvedeniya trometamolovoi soli tioktovoi (α-lipoevoi) kisloty pri diabeticheskoi polineiropatii. Zhurn nevrol i psikhiat 1999; 99: 6: 18-22.
Strokov I.A. Farmakoterapiya diabeticheskoi polineiropatii: real'nost' i perspektivy. Nevrol zhurn 2001;5: 4-8.
Appel S. ALS: immune factors in motor neuron cell injury. In: Neurobiology of ALS: education program syllabus. Minneapolis. Am Acad Neurol 1999;101-113.
Biesenbach G., Grafinger P., Eichbauer-Sturm G. et al. Cerebrolysin in treatment of painful diabetic neuropathy. Wien Med Wochenschr 1997; 147: 3: 63-66.
Calcutt N.A., Jolivant C.G., Fernyhough P. et al. Growth factors as therapeutics for diabetic neuropathy. Curr Drug Tatgets 2008; 9: 47-59.
Carrett N.E., Malcangio M., Dewhurst M. et al. α-Lipoic acid corrects neuropeptide deficits in diabetic rats via induction of trophic support. Neurosci Lett 1997; 222: 191-194.
Daousi C., MacFarlane I.A., Woodward A. et al. Chronic painful peripheral neuropathy in a urban community: a controlled comparison of people with and without diabetes. Diabet Med 2004; 21: 976-982.
Ropper A.H., Gorson K.C., Gooch C.L. et al. Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trial. Ann Neurol 2009; 65: 386-393.
Sinnreich M., Taylor B.V., Dyck P.J. Diabetic neuropathies. Classification, clinical features and pathophysiological basis. Neurologia 2005; 11: 2: 63-79.
Vinik A., Maser R., Mitchell B. et al. Diabetic Autonomic Neuropathy. Diabet Care 2003; 26: 1553-1579.
Vinik A., Ullal J., Parson H.K. et al. Diabetic neuropathies: clinical manifestations and current treatment options. Nat Clin Pract Endocrinol Metabol 2006; 2: 4: 1-13.
Waldmeier P.C. Prospects for antiapoptotic drug therapy of neurodegenerative diseases. Prog Neuropsychopharmacol Biol Psychiat 2003; 27: 2: 303-321.
Ziegler D., Reljanovic M., Mehnert H. et al. α-Lipoic acid in the treatment of diabetic polyneuropathy in germany: current evidence from clinical trials. Exp Clin Endocrinol Diabet 1999; 107: 421-430.
Ziegler D. Treatment of diabetic neuropathy and neuropathic pain. Diabet Care 2008; 31: 2: 255-261.
Zochodne D.W. Diabetes mellitus and the peripheral nervous system: manifestation and mechanisms. Muscle Nerve 2007; 36: 144-166.